In addition, based on the three-dimensional (3D) structure of the G6PD protein and using in silico approaches to mine structural information on the effects of the G6PD variants, we identified modifications in the protein structure to understand the clinical symptoms of these mutations in order to explain the molecular mechanisms observed in patients with G6PD deficiency. Here, G6PD is linked to G6PD deficiency.